JGC
PRTK
J. Goldman & Co’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-758,431
| Closed | -$1.68M | – | 397 |
|
|
2023
Q2 | $1.68M | Sell |
758,431
-157,070
| -17% | -$347K | 0.06% | 142 |
|
|
2023
Q1 | $2.33M | Buy |
915,501
+865,126
| +1,717% | +$2.2M | 0.09% | 138 |
|
|
2022
Q4 | $94.2K | Sell |
50,375
-408,625
| -89% | -$764K | ﹤0.01% | 245 |
|
|
2022
Q3 | $1.18M | Buy |
459,000
+438,647
| +2,155% | +$1.13M | 0.06% | 168 |
|
|
2022
Q2 | $39K | Sell |
20,353
-1,036,278
| -98% | -$1.99M | ﹤0.01% | 223 |
|
|
2022
Q1 | $3.14M | Buy |
+1,056,631
| New | +$3.14M | 0.14% | 112 |
|
|
2020
Q3 | – | Sell |
-83,334
| Closed | -$435K | – | 324 |
|
|
2020
Q2 | $435K | Sell |
83,334
-104,421
| -56% | -$545K | 0.03% | 167 |
|
|
2020
Q1 | $591K | Buy |
187,755
+87,755
| +88% | +$276K | 0.07% | 119 |
|
|
2019
Q4 | $403K | Sell |
100,000
-58,650
| -37% | -$236K | 0.03% | 148 |
|
|
2019
Q3 | $685K | Buy |
+158,650
| New | +$685K | 0.05% | 120 |
|